Volpara Health Technologies Limited Stock

Equities

VHT

NZVHTE0001S6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:44 2024-04-26 am EDT 5-day change 1st Jan Change
1.14 AUD 0.00% Intraday chart for Volpara Health Technologies Limited 0.00% +3.17%
Sales 2024 * 41.42M 27.12M Sales 2025 * 49.13M 32.17M Capitalization 290M 190M
Net income 2024 * -5M -3.27M Net income 2025 * - 0 EV / Sales 2024 * 6.83 x
Net cash position 2024 * 6.91M 4.52M Net cash position 2025 * 12.32M 8.07M EV / Sales 2025 * 5.65 x
P/E ratio 2024 *
-51.7 x
P/E ratio 2025 *
-792 x
Employees 156
Yield 2024 *
-
Yield 2025 *
-
Free-Float 74.97%
More Fundamentals * Assessed data
Dynamic Chart
Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover MT
Transcript : Volpara Health Technologies Limited - Shareholder/Analyst Call
Volpara Health Technologies Limited Launches MQSA Compliance Software at the Society for Breast Imaging Symposium CI
Volpara Health Technologies Ltd. to Showcase AI Software for Breast Centers at NCBC 2024 CI
Volpara Health Technologies Ltd. to Highlight Growing Ai Suite for Mammography At ECR 2024, Including New Lunit Distribution Agreement CI
Lunit to Take Over Volpara Health; Lunit Shares Decline 4% MT
Lunit Inc. agreed to acquire Volpara Health Technologies Limited from Harbour Asset Management Limited and others for AUD300 million. CI
Transcript : Volpara Health Technologies Limited, H1 2024 Earnings Call, Nov 21, 2023
Volpara Health Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Transcript : Volpara Health Technologies Limited, Q2 2024 Earnings Call, Oct 17, 2023
Volpara Health Technologies Divests Interest in Software Company RevealDX MT
An Unknown buyer acquired 4% stake in Reveal DX fromVolpara Health Technologies Limited. CI
Transcript : Volpara Health Technologies Limited - Shareholder/Analyst Call
Transcript : Volpara Health Technologies Limited, Q1 2024 Earnings Call, Jul 21, 2023
Volpara Health Technologies Secures AU$1.4 Million Contract for Mammography Screening Software MT
More news

Latest transcript on Volpara Health Technologies Limited

Current month+0.44%
1 month+0.44%
3 months+2.24%
6 months+74.05%
Current year+3.17%
More quotes
1 week
1.14
Extreme 1.14
1.15
1 month
1.13
Extreme 1.13
1.15
Current year
1.10
Extreme 1.1
1.15
1 year
0.63
Extreme 0.625
1.15
3 years
0.40
Extreme 0.4
1.37
5 years
0.40
Extreme 0.4
2.17
10 years
0.30
Extreme 0.3
2.17
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-04-19
Founder - 08-12-31
Director of Finance/CFO - 16-06-30
Members of the board TitleAgeSince
Director/Board Member - 10-05-31
Director/Board Member - 14-12-31
Director/Board Member - 20-01-30
More insiders
Date Price Change Volume
24-04-26 1.14 0.00% 1 436 577
24-04-24 1.14 0.00% 1,385,421
24-04-23 1.14 0.00% 70,916
24-04-22 1.14 0.00% 71,273
24-04-19 1.14 0.00% 935,592

Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT

More quotes
Volpara Health Technologies Limited is a New Zealand-based company, which makes software for healthcare providers to understand cancer risk, enabling patients to make personal care decisions and guide recommendations about additional imaging, genetic testing and other interventions. Its artificial intelligence (AI)-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression and dose. Its software streamlines operations and provides performance insights that support continuous quality improvement. Its software is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware and genetic laboratories.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
1.14 AUD
Average target price
0.9959 AUD
Spread / Average Target
-12.64%
Consensus

Quarterly revenue - Rate of surprise